Hope for people with severe alcohol-associated hepatitis thanks to epigenetic therapy
A ‘transformational’ treatment for people with severe alcohol-associated hepatitis (AH) has today (May 21) been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Administration (FDA).